Compare Edwards Lifesciences Corporation Common Stock (EW) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs The Coca-Cola Co K — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while The Coca-Cola Co K trades at $87.49 (market cap $377.63B). The key difference: The Coca-Cola Co K is far larger — about 7.8× Edwards Lifesciences Corporation Common Stock's market cap, and The Coca-Cola Co K pays a 2.42% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | KO | |
|---|---|---|
Market Cap | $48.56B | $377.63B |
Volume | 6,520,488 | 14,894,568 |
Sector | Health | Consumer Staples |
52-Week High | $95.18 | $91.99 |
52-Week Low | $72.65 | $66.37 |
Enterprise Value | $45.01B | $404.81B |
Typical Hold Time | — | 154 Days |
Dividend Yield | — | 2.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Coca-Cola (KO) trades at $85.82, down 0.41% on the day, with technical indicators showing bearish momentum despite strong fundamentals. The company reported consistent earnings beats in recent quarters with Q2 2026 EPS of $0.97 beating expectations of $0.92. Revenue growth remains steady at $47.94B for 2025, with net income margin improving to 28.56%. Analyst consensus remains bullish with a $95.75 price target, representing 11.6% upside potential from current levels.
The stock presents a compelling dividend opportunity with 64 consecutive years of dividend increases, though technical weakness and regional demand divergence pose near-term risks. Long-term investors may find value in the company's stable cash flows and global brand strength, while short-term traders should monitor support at $85 for potential entry points.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
